Eribulin (E) and capecitabine (C), a combined treatment schedule in elderly metastatic breast cancer (EMBC): Efficacy and safety evaluation (E&S).
Ignazio Ugo Carreca
No relevant relationships to disclose
Paolo D'alia
No relevant relationships to disclose
Giuseppe Bronte
No relevant relationships to disclose
Viviana Bazan
No relevant relationships to disclose
Dario Cova
No relevant relationships to disclose
Paolo Foa
No relevant relationships to disclose
Antonio Russo
No relevant relationships to disclose